CytoDyn Inc. Unrealized Gain (Loss) on Derivatives
CytoDyn Inc. (CYDY) reported Unrealized Gain (Loss) on Derivatives of -$6.00 thousand for the 12-month period ending 2023-05-31, per its 10-K filed 2024-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2024-08-15
- CytoDyn Inc. unrealized gain (loss) on derivatives for the quarter ending 2020-05-31 was -$7.44M.
- CytoDyn Inc. unrealized gain (loss) on derivatives for the quarter ending 2020-02-29 was -$2.93M.
- CytoDyn Inc. unrealized gain (loss) on derivatives for fiscal 2023 was -$6.00K.
- CytoDyn Inc. unrealized gain (loss) on derivatives for fiscal 2020 was -$9.54M, a 672.75% decline from fiscal 2019.
- CytoDyn Inc. unrealized gain (loss) on derivatives for fiscal 2019 was $1.67M.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2023-05-31 | -$6.00K 10-K · filed 2024-08-15 | |||
| 2020-05-31 | -$7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-15 | -$10.37M derived: sum of 2 quarters · filed 2022-08-15 | -$9.54M 10-K · filed 2022-08-15 | |
| 2020-02-29 | -$2.93M 10-Q · filed 2021-04-14 | -$2.10M 10-Q · filed 2021-04-14 | ||
| 2019-05-31 | $1.67M 10-K · filed 2021-07-30 |